UHRF2
Basic information
Region (hg38): 9:6413151-6507056
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UHRF2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 26 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 1 | 0 |
Variants in UHRF2
This is a list of pathogenic ClinVar variants found in the UHRF2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-6413513-T-C | not specified | Uncertain significance (Nov 13, 2024) | ||
9-6413540-A-G | not specified | Uncertain significance (Dec 15, 2023) | ||
9-6413602-G-T | not specified | Uncertain significance (Jan 20, 2023) | ||
9-6421013-A-G | Likely benign (Feb 01, 2023) | |||
9-6421036-C-G | not specified | Uncertain significance (Oct 25, 2023) | ||
9-6421066-C-G | not specified | Uncertain significance (Apr 15, 2024) | ||
9-6421069-G-A | not specified | Uncertain significance (Jun 11, 2024) | ||
9-6421072-T-C | not specified | Uncertain significance (May 06, 2022) | ||
9-6421096-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
9-6421104-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
9-6421117-T-C | not specified | Uncertain significance (Feb 28, 2024) | ||
9-6421135-T-C | not specified | Uncertain significance (Apr 27, 2022) | ||
9-6433989-G-T | not specified | Uncertain significance (Jan 26, 2022) | ||
9-6434001-C-G | not specified | Uncertain significance (Nov 15, 2024) | ||
9-6434038-C-A | not specified | Uncertain significance (Mar 07, 2024) | ||
9-6434080-A-G | not specified | Uncertain significance (Jan 16, 2024) | ||
9-6434088-A-C | not specified | Uncertain significance (Aug 02, 2021) | ||
9-6434148-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
9-6434152-T-C | not specified | Uncertain significance (Jun 16, 2024) | ||
9-6460604-G-A | not specified | Uncertain significance (Apr 06, 2024) | ||
9-6460670-G-A | not specified | Uncertain significance (Aug 06, 2024) | ||
9-6460714-C-G | not specified | Uncertain significance (Mar 23, 2023) | ||
9-6460772-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
9-6477625-G-A | not specified | Uncertain significance (Aug 01, 2022) | ||
9-6477636-G-C | not specified | Uncertain significance (Jun 30, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UHRF2 | protein_coding | protein_coding | ENST00000276893 | 16 | 93904 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000716 | 125739 | 0 | 8 | 125747 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.32 | 244 | 440 | 0.554 | 0.0000227 | 5235 |
Missense in Polyphen | 90 | 262.04 | 0.34345 | 3121 | ||
Synonymous | -2.44 | 187 | 149 | 1.25 | 0.00000739 | 1532 |
Loss of Function | 5.37 | 5 | 43.0 | 0.116 | 0.00000233 | 529 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000354 | 0.0000352 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase that is an intermolecular hub protein in the cell cycle network. Through cooperative DNA and histone binding, may contribute to a tighter epigenetic control of gene expression in differentiated cells. Ubiquitinates cyclins, CCND1 and CCNE1, in an apparently phosphorylation-independent manner and induces G1 arrest. Also ubiquitinates PCNP leading to its degradation by the proteasome. E3 SUMO-, but not ubiquitin-, protein ligase for ZNF131. {ECO:0000269|PubMed:12176013, ECO:0000269|PubMed:14741369, ECO:0000269|PubMed:15178429, ECO:0000269|PubMed:15361834, ECO:0000269|PubMed:21952639, ECO:0000269|PubMed:23404503}.;
- Disease
- DISEASE: Note=Associated with various cancers. DNA copy number loss is found in multiple kinds of malignancies originating from the brain, breast, stomach, kidney, hematopoietic tissue and lung.;
Recessive Scores
- pRec
- 0.138
Intolerance Scores
- loftool
- 0.0576
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 27.88
Haploinsufficiency Scores
- pHI
- 0.263
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.582
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.995
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Uhrf2
- Phenotype
- skeleton phenotype; homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- cell cycle;cell population proliferation;maintenance of DNA methylation;protein ubiquitination;protein sumoylation;cell differentiation;regulation of cell cycle;protein autoubiquitination;positive regulation of cell cycle arrest
- Cellular component
- nucleus;nucleoplasm;nuclear heterochromatin
- Molecular function
- DNA binding;ubiquitin-protein transferase activity;protein binding;SUMO transferase activity;histone binding;metal ion binding;ubiquitin protein ligase activity